-
CD40 and STING Competition Drives IRF4+ B Cell Activation in
2026-05-02
This study reveals how competitive binding between CD40 and STING with TRAF2 regulates IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). The findings uncover a mechanistic link between local immunity and tumor prognosis, offering new avenues for biomarker and therapeutic target development.
-
Synergistic PI3K–AKT–ERK Blockade Overcomes Gefitinib Resist
2026-05-01
Deng et al. developed a rational nanoplatform for co-delivery of gefitinib and crizotinib, achieving dual PI3K–AKT and ERK pathway suppression in lung adenocarcinoma models. This approach addresses both drug resistance and metastasis, offering a clinically translatable strategy for overcoming the limitations of current EGFR-TKI therapies.
-
IR-1061: Near Infrared Fluorescent Dye for In Vivo Imaging
2026-05-01
IR-1061 stands out as a near infrared fluorescent dye optimized for deep tissue and vascular imaging, offering robust signal clarity with minimal autofluorescence. This guide translates cutting-edge research into actionable workflows, troubleshooting, and comparative insights for biomedical imaging experiments.
-
Applied Protocols with Minocycline HCl in Inflammation Resea
2026-04-30
Minocycline HCl stands out as both a powerful antimicrobial and a versatile anti-inflammatory agent, uniquely suited for scalable inflammation and neuroprotection assays. This article delivers hands-on workflows, troubleshooting insights, and data-driven optimization tips for deploying minocycline hydrochloride in advanced cell and EV-based research.
-
Oxaliplatin in Cancer Biology: Resistance, Mechanisms, and A
2026-04-30
Explore the multifaceted role of Oxaliplatin, a platinum-based chemotherapeutic agent, in cancer biology research. This article uniquely dissects resistance mechanisms and offers actionable strategies for leveraging Oxaliplatin in DNA damage, apoptosis, and chemoresistance assays.
-
Stroma-Mediated Chemoresistance in PDAC: 3D Organoid-CAF Mod
2026-04-29
Schuth et al. introduce a patient-specific 3D co-culture system for pancreatic cancer, integrating tumor organoids with matched cancer-associated fibroblasts to model stroma-driven chemoresistance. This approach reveals critical tumor-stroma interactions underpinning drug resistance and provides a robust platform for personalized oncology studies.
-
SGI-1027 Induces Mitochondrial Apoptosis in HCC Cells
2026-04-29
This study establishes SGI-1027 as a potent DNA methyltransferase inhibitor that induces dose-dependent apoptosis in Huh7 hepatocellular carcinoma cells via the mitochondrial pathway. The findings advance understanding of epigenetic modulation as a strategy for tumor suppressor gene reactivation and targeted cancer therapy.
-
FASN Inhibition Primes Cancer Cells for Apoptosis via BCL-2
2026-04-28
This study reveals that fatty acid synthase (FASN) inhibition in cancer cells heightens mitochondrial apoptotic priming by upregulating pro-apoptotic BH3-only proteins. The findings demonstrate that FASN blockade sensitizes tumors to BCL-2 family inhibitors such as ABT-263 (Navitoclax), providing a mechanistic foundation for rational combination therapies in oncology.
-
Low-Dose Orlistat Enhances Oxaliplatin Efficacy in Colorecta
2026-04-28
This study demonstrates that low-dose orlistat synergistically enhances the antitumor effect of oxaliplatin in colorectal cancer models by increasing apoptosis through molecular crosstalk. The findings provide mechanistic insights and a rationale for combination strategies to overcome chemoresistance in metastatic colorectal cancer therapy.
-
Macrophage EVs Enclosed miR-660 Drives Breast Cancer Metasta
2026-04-27
This study uncovers a key tumor-promoting mechanism in breast cancer, demonstrating that microRNA-660, packaged within extracellular vesicles from tumor-associated macrophages, enhances metastatic progression via the KLHL21/IKKβ/NF-κB p65 axis. The findings highlight a potential therapeutic target and deepen our understanding of cell–cell communication in the tumor microenvironment.
-
Anti-Inflammatory, Anti-Angiogenic Airway Stent Suppresses T
2026-04-27
Zhao et al. engineered a dual-function airway stent combining anti-inflammatory and anti-angiogenic activities to address tracheal in-stent restenosis (TISR). Their approach demonstrated reduced fibrosis, angiogenesis, and microbial colonization in preclinical models, highlighting a promising translational advance for airway stenting complications.
-
Acetylcysteine in Advanced Tumor Microenvironment Modeling
2026-04-26
Explore how Acetylcysteine drives innovation in tumor microenvironment and chemoresistance research. This in-depth review highlights unique mechanistic insights and protocol strategies for leveraging N-acetyl-L-cysteine in complex 3D co-culture assays.
-
TaqI Restriction Endonuclease: Rapid, Specific DNA Digestion
2026-04-25
TaqI Restriction Endonuclease (SKU K3053) offers a rapid and reliable solution for specific DNA cleavage in plasmid, PCR product, or genomic DNA workflows. It is designed for research use only, supporting applications where expedited, sticky-end DNA digestion is essential and should not be used for diagnostic or medical purposes.
-
Anti-ROR1 Antibody (Zilovertamab): Mechanistic Precision in
2026-04-24
Explore how Anti-ROR1 Antibody (Zilovertamab) advances tumor-stroma modeling by targeting Wnt5a-induced ROR1 signaling. This article delivers a unique mechanistic and experimental perspective distinct from existing content.
-
Short-Scale DNA Replication and Damage Amplification in Mous
2026-04-24
This paper reveals how double-strand DNA breaks (DSBs) trigger short-scale break-induced replication (ssBIR) and amplify DNA damage in fully grown mouse oocytes. The study introduces experimental strategies—including the use of chain-terminating nucleotide analogs like ddATP—to dissect the mechanisms and regulatory factors of repair pathway initiation, offering new insight into genome stability in reproductive cells.